Is Lisinopril (ACE Inhibitor) safe in pregnancy?

Common uses

High blood pressure

How Lisinopril (ACE Inhibitor) works and why pregnancy changes the math

Lisinopril (ACE Inhibitor) blocks part of the renin-angiotensin system, which lowers blood pressure by reducing how strongly your blood vessels constrict. In pregnancy that mechanism becomes a real problem because the same system is critical for fetal kidney development and amniotic fluid production.

Second- and third-trimester exposure to ACE inhibitors or ARBs is associated with a specific syndrome of fetal renal failure, oligohydramnios (low amniotic fluid), pulmonary hypoplasia, and skull deformities. First-trimester exposure has been associated with a separate set of cardiovascular and central nervous system defects in some studies. This is one of the small number of medications that should be stopped as soon as pregnancy is recognized, with an immediate switch to pregnancy-safe blood pressure medications.

How Lisinopril (ACE Inhibitor) risk changes by trimester

The clinical reasoning behind the verdict

ACE inhibitors cause fetal renal failure in 2nd/3rd trimesters. 1st trimester also has risks.

Dosing and what to do if symptoms keep going

Pregnancy dosing for Lisinopril (ACE Inhibitor) generally follows standard adult guidance unless your provider has directed otherwise. Pregnancy changes how your body absorbs, distributes, and clears many medications, so doses that worked before may need adjustment as pregnancy progresses.

If symptoms are not responding to standard dosing of Lisinopril (ACE Inhibitor), that is a conversation with your prescriber rather than a reason to escalate on your own. Pregnancy is a time when changes to medication should happen with provider involvement, both because the underlying condition may be evolving and because pregnancy-safe alternatives may be available.

Safer alternatives and how to choose between them

Switch to labetalol or methyldopa for pregnancy hypertension.

For pregnancy hypertension, labetalol and methyldopa are the two most-established alternatives to ACE inhibitors and ARBs. Both have decades of safety data in pregnancy and effectively control blood pressure for most patients. Nifedipine is another option that works well for some.

The switch off an ACE inhibitor or ARB should ideally happen before pregnancy when planning, or immediately when pregnancy is confirmed. Stopping the medication entirely is rarely the answer — uncontrolled hypertension carries its own pregnancy risks — so the move is a same-day or same-week switch under provider direction.

What recent research has been saying about Lisinopril (ACE Inhibitor)

The literature on Lisinopril (ACE Inhibitor) in pregnancy continues to evolve as more population-level data accumulates and as researchers control more carefully for confounding factors. The pregnancy-specific evidence base for any given medication is rarely as deep as the general adult evidence base, so cautious clinical interpretation and individualized provider conversation remain the right approach as guidance updates.

Sources and further reading

FDA ACE Inhibitor Warning